Comparison / Level C vs Level D

Cortexin vs Pinealon

Research Verdict

Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.

Quick Answers

Which is better, Cortexin or Pinealon?

Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.

What is the key difference between Cortexin and Pinealon?

Cortexin is a bovine brain extract with variable composition; pinealon is a synthetic tripeptide with a defined sequence - fundamentally different from a pharmaceutical characterization standpoint.

Evidence Comparison

Cortexin: Russian clinical studies across neurological conditions, decades of use. Pinealon: Khavinson tripeptide (Glu-Asp-Arg), single research group, minimal clinical data. Cortexin has more clinical experience; pinealon has better molecular definition.

Evidence Context Favoring Cortexin

Russian clinical practice where cortexin has established usage and physician familiarity.

Evidence Context Favoring Pinealon

Research requiring a molecularly defined peptide bioregulator with reproducible synthesis.

Side-by-Side Snapshot

Evidence gradeCortexin: Level C
Pinealon: Level D
Research statusCortexin: Approved Outside US
Pinealon: Early Research
Primary categoryCortexin: Cognitive & Nootropic
Pinealon: Cognitive & Nootropic
Cited studiesCortexin: 2
Pinealon: 2

Read Next